Page 87 - Read Online
P. 87
Page 16 of 16 Annibali et al. Mini-invasive Surg 2022;6:12 https://dx.doi.org/10.20517/2574-1225.2021.101
91. Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device
during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J 2015;36:2070-8. DOI PubMed
92. Kapadia SR, Kodali S, Makkar R, et al; SENTINEL Trial Investigators. Protection against cerebral embolism during transcatheter
aortic valve replacement. J Am Coll Cardiol 2017;69:367-77. DOI PubMed
93. Shimamura J, Kuno T, Malik A, et al. Safety and efficacy of cerebral embolic protection devices in patients undergoing transcatheter
aortic valve replacement: a meta-analysis of in-hospital outcomes. Cardiovasc Interv Ther 2021. DOI PubMed
